Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Drug Utilization"" wg kryterium: Temat


Tytuł :
COVID-19 Outbreak Impact on Anticoagulants Utilization: An Interrupted Time-Series Analysis Using Health Care Administrative Databases.
Autorzy :
Antonazzo IC; Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy.
Fornari C; Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy.
Paoletti O; Osservatorio di Epidemiologia, Agenzia Regionale di Sanità della Toscana, Florence, Italy.
Bartolini C; Osservatorio di Epidemiologia, Agenzia Regionale di Sanità della Toscana, Florence, Italy.
Conti S; Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy.; Value-based Healthcare Unit, IRCCS MultiMedica, Sesto San Giovanni, Italy.
Cortesi PA; Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy.; Value-based Healthcare Unit, IRCCS MultiMedica, Sesto San Giovanni, Italy.
Mantovani LG; Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy.; Value-based Healthcare Unit, IRCCS MultiMedica, Sesto San Giovanni, Italy.
Gini R; Osservatorio di Epidemiologia, Agenzia Regionale di Sanità della Toscana, Florence, Italy.
Mazzaglia G; Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy.
Pokaż więcej
Źródło :
Thrombosis and haemostasis [Thromb Haemost] 2021 Aug; Vol. 121 (8), pp. 1115-1118. Date of Electronic Publication: 2021 Jun 07.
Typ publikacji :
Letter
MeSH Terms :
COVID-19*/epidemiology
Drug Utilization*
Anticoagulants/*therapeutic use
Adult ; Cardiovascular Diseases/drug therapy ; Disease Outbreaks ; Health Services Accessibility ; Humans
Opinia redakcyjna
Tytuł :
Change-points in antibiotic consumption in the community, European Union/European Economic Area, 1997-2017.
Autorzy :
Bruyndonckx R; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Data Science Institute, Hasselt University, Hasselt, Belgium.
Hoxha A; Sciensano, Brussels, Belgium.
Quinten C; Disease Programmes Unit, European Centre for Disease Prevention and Control, Stockholm, Sweden.
Ayele GM; Allergan Plc, 5 Giralda Farms, Madison NJ, USA.
Coenen S; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.; Centre for General Practice, Department of Family Medicine & Population Health (FAMPOP), University of Antwerp, Antwerp, Belgium.
Versporten A; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
Adriaenssens N; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.; Centre for General Practice, Department of Family Medicine & Population Health (FAMPOP), University of Antwerp, Antwerp, Belgium.
Muller A; Disease Programmes Unit, European Centre for Disease Prevention and Control, Stockholm, Sweden.
Heuer O; Disease Programmes Unit, European Centre for Disease Prevention and Control, Stockholm, Sweden.
Monnet DL; Disease Programmes Unit, European Centre for Disease Prevention and Control, Stockholm, Sweden.
Goossens H; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
Molenberghs G; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Data Science Institute, Hasselt University, Hasselt, Belgium.; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Catholic University of Leuven, Leuven, Belgium.
Weist K; Disease Programmes Unit, European Centre for Disease Prevention and Control, Stockholm, Sweden.
Hens N; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Data Science Institute, Hasselt University, Hasselt, Belgium.; Centre for Health Economic Research and Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
Pokaż więcej
Corporate Authors :
ESAC-Net study group
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jul 26; Vol. 76 (12 Suppl 2), pp. ii68-ii78.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Anti-Bacterial Agents*/therapeutic use
Drug Utilization*
Europe ; European Union ; Humans
Czasopismo naukowe
Tytuł :
Consumption of antibiotics in the community, European Union/European Economic Area, 1997-2017: data collection, management and analysis.
Autorzy :
Bruyndonckx R; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Data Science Institute, Hasselt University, Hasselt, Belgium.
Adriaenssens N; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.; Centre for General Practice, Department of Family Medicine & Population Health (FAMPOP), University of Antwerp, Antwerp, Belgium.
Versporten A; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
Hens N; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Data Science Institute, Hasselt University, Hasselt, Belgium.; Centre for Health Economic Research and Modelling Infectious Diseases, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
Monnet DL; Disease Programmes Unit, European Centre for Disease Prevention and Control, Stockholm, Sweden.
Molenberghs G; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Data Science Institute, Hasselt University, Hasselt, Belgium.; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Catholic University of Leuven, Leuven, Belgium.
Goossens H; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
Weist K; Disease Programmes Unit, European Centre for Disease Prevention and Control, Stockholm, Sweden.
Coenen S; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.; Centre for General Practice, Department of Family Medicine & Population Health (FAMPOP), University of Antwerp, Antwerp, Belgium.
Pokaż więcej
Corporate Authors :
ESAC-Net study group
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jul 26; Vol. 76 (12 Suppl 2), pp. ii2-ii6.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Bacterial Agents*/therapeutic use
Drug Utilization*
Data Collection ; Europe ; European Union ; Humans
Czasopismo naukowe
Tytuł :
Analysing the trend over time of antibiotic consumption in the community: a tutorial on the detection of common change-points.
Autorzy :
Bruyndonckx R; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Data Science Institute, Hasselt University, Hasselt, Belgium.
Coenen S; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.; Centre for General Practice, Department of Family Medicine & Population Health (FAMPOP), University of Antwerp, Antwerp, Belgium.
Adriaenssens N; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.; Centre for General Practice, Department of Family Medicine & Population Health (FAMPOP), University of Antwerp, Antwerp, Belgium.
Versporten A; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
Monnet DL; Disease Programmes, European Centre for Disease Prevention and Control, Stockholm, Sweden.
Goossens H; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
Molenberghs G; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Data Science Institute, Hasselt University, Hasselt, Belgium.; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Catholic University of Leuven, Leuven, Belgium.
Weist K; Disease Programmes, European Centre for Disease Prevention and Control, Stockholm, Sweden.
Hens N; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Data Science Institute, Hasselt University, Hasselt, Belgium.; Centre for Health Economic Research and Modelling Infectious Diseases, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
Pokaż więcej
Corporate Authors :
ESAC-Net study group
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jul 26; Vol. 76 (12 Suppl 2), pp. ii79-ii85.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Bacterial Agents*/therapeutic use
Drug Utilization*
Europe ; Humans
Czasopismo naukowe
Tytuł :
Effect of the coronavirus disease 2019 pandemic on antibiotic use in primary care.
Autorzy :
Peñalva G; Department of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville, University Hospital Virgen del Rocio, Spanish National Research Council, University of Seville, Seville, Spain.
Benavente RS; Promotion of Rational Use of Medicines Service, Sub-Directorate of Pharmacy and Provisions, Directorate General of Healthcare and Outcomes in Health, Andalusian Healthcare Service, Seville, Spain.
Pérez-Moreno MA; Clinical Unit of Pharmacy, University Hospital Virgen del Rocio, Institute of Biomedicine of Seville, Seville, Spain.
Pérez-Pacheco MD; Primary Care Pharmacy Service, Clinical Unit of Pharmacy, Health Management Area of Jerez, Costa Noroeste and Sierra de Cadiz, Jerez de la Frontera, Spain.
Pérez-Milena A; Primary Healthcare Centre El Valle, Jaen, Spain.
Murcia J; Primary Care Pediatrics Coordination, Clinical Management Unit Bulevar, Health District of Jaen, Spain.
Cisneros JM; Department of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville, University Hospital Virgen del Rocio, Spanish National Research Council, University of Seville, Avda. Manuel Siurot s/n, 41013, Seville, Spain. Electronic address: .
Pokaż więcej
Źródło :
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2021 Jul; Vol. 27 (7), pp. 1058-1060. Date of Electronic Publication: 2021 Feb 02.
Typ publikacji :
Letter
MeSH Terms :
Drug Utilization*
SARS-CoV-2*
Anti-Bacterial Agents/*administration & dosage
COVID-19/*epidemiology
Cross-Sectional Studies ; Humans ; Primary Health Care ; Spain/epidemiology ; Time Factors
Opinia redakcyjna
Tytuł :
Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: An interrupted time series analysis.
Autorzy :
Sulis G; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.; McGill International TB Centre, McGill University, Montreal, Quebec, Canada.
Batomen B; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Kotwani A; Department of Pharmacology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India.
Pai M; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.; McGill International TB Centre, McGill University, Montreal, Quebec, Canada.
Gandra S; Division of Infectious Diseases, Department of Medicine, Washington University in St. Louis, Saint Louis, Missouri, United States of America.
Pokaż więcej
Źródło :
PLoS medicine [PLoS Med] 2021 Jul 01; Vol. 18 (7), pp. e1003682. Date of Electronic Publication: 2021 Jul 01 (Print Publication: 2021).
Typ publikacji :
Journal Article
MeSH Terms :
SARS-CoV-2*
Anti-Bacterial Agents/*economics
COVID-19/*drug therapy
Drug Utilization/*statistics & numerical data
Hydroxychloroquine/*economics
Pandemics/*economics
Anti-Bacterial Agents/supply & distribution ; Anti-Bacterial Agents/therapeutic use ; COVID-19/economics ; Commerce/statistics & numerical data ; Drug Compounding ; Drug Utilization/economics ; Humans ; Hydroxychloroquine/supply & distribution ; Hydroxychloroquine/therapeutic use ; India ; Interrupted Time Series Analysis ; Pandemics/statistics & numerical data
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
Non-antibiotic medication use in an Indonesian community cohort 0-18 months of age.
Autorzy :
At Thobari J; Department of Pharmacology and Therapy, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, Indonesia.; Pediatric Research Office, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, Indonesia.; Department of Paediatrics, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, Indonesia.
Satria CD; Pediatric Research Office, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, Indonesia.; Department of Paediatrics, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, Indonesia.
Ridora Y; Pediatric Research Office, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, Indonesia.
Watts E; RV3 Rotavirus Vaccine Program, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Handley A; RV3 Rotavirus Vaccine Program, Murdoch Children's Research Institute, Parkville, Victoria, Australia.; Medicines Development for Global Health, Melbourne, Victoria, Australia.
Standish J; RV3 Rotavirus Vaccine Program, Murdoch Children's Research Institute, Parkville, Victoria, Australia.; Department of General Medicine, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.
Bachtiar NS; PT Bio Farma, Bandung, West Java, Indonesia.
Buttery JP; RV3 Rotavirus Vaccine Program, Murdoch Children's Research Institute, Parkville, Victoria, Australia.; Department of Pediatrics, University of Melbourne, Melbourne, Victoria, Australia.; Department of Paediatrics, Monash University, Clayton, Victoria, Australia.; School of Public Health and Preventive Medicine, Monash University, Clayton, Victoria, Australia.; Department of Infection and Immunity, Monash Children's Hospital, Clayton, Victoria, Australia.
Soenarto Y; Pediatric Research Office, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, Indonesia.; Department of Paediatrics, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, Indonesia.
Bines JE; RV3 Rotavirus Vaccine Program, Murdoch Children's Research Institute, Parkville, Victoria, Australia.; Department of Pediatrics, University of Melbourne, Melbourne, Victoria, Australia.; Department of Gastroenterology and Clinical Nutrition, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Nov 18; Vol. 15 (11), pp. e0242410. Date of Electronic Publication: 2020 Nov 18 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Therapy/*trends
Drug Utilization/*statistics & numerical data
Drug Utilization/*trends
Analgesics ; Antipyretics ; Drug Therapy/statistics & numerical data ; Drug Utilization Review/methods ; Female ; Histamine Antagonists ; Humans ; Indonesia/epidemiology ; Infant ; Infant, Newborn ; Male ; Pharmaceutical Preparations
Czasopismo naukowe
Tytuł :
Choppy waters: The importance of accounting for shifting drug utilization during the COVID-19 pandemic in future observational drug-related studies.
Autorzy :
Shakeri A; Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada.
Gomes T; Unity Health Toronto, Toronto, ON, Canada.; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
Suda K; Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA.; Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Tadrous M; Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada.; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.
Pokaż więcej
Źródło :
Basic & clinical pharmacology & toxicology [Basic Clin Pharmacol Toxicol] 2021 May; Vol. 128 (5), pp. 649-651. Date of Electronic Publication: 2021 Feb 19.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*/drug therapy
COVID-19*/epidemiology
Chronic Disease*/drug therapy
Chronic Disease*/epidemiology
Drug Utilization*/statistics & numerical data
Drug Utilization*/trends
Pharmaceutical Preparations*/classification
Pharmaceutical Preparations*/supply & distribution
Pharmacoepidemiology*/methods
Pharmacoepidemiology*/trends
Strategic Stockpile*/methods
Strategic Stockpile*/statistics & numerical data
Canada/epidemiology ; Drug-Related Side Effects and Adverse Reactions/prevention & control ; Forecasting ; Humans ; Medication Adherence/statistics & numerical data ; Practice Patterns, Physicians' ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Off-label postpartum use of domperidone in Canada: a multidatabase cohort study.
Autorzy :
Moriello C; Centre for Clinical Epidemiology (Moriello, Reynier, Aibibula, Filion), Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Que; ICES (Paterson); Institute of Health Policy, Management and Evaluation (Paterson), University of Toronto, Toronto, Ont.; Manitoba Centre for Health Policy, Department of Community Health Sciences (Dahl, Kuo), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; Department of Anesthesiology, Pharmacology and Therapeutics (Fisher), University of British Columbia, Vancouver BC; School of Pharmacy (Gamble), University of Waterloo, Kitchener, Ont.; Department of Community Health Sciences (Ronksley), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Saskatchewan Health Quality Council (Winquist); Department of Community Health and Epidemiology (Winquist), College of Medicine, University of Saskatchewan, Saskatoon Sask.; Departments of Medicine and of Epidemiology, Biostatistics, and Occupational Health (Filion), McGill University, Montréal, Que.
Paterson JM; Centre for Clinical Epidemiology (Moriello, Reynier, Aibibula, Filion), Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Que; ICES (Paterson); Institute of Health Policy, Management and Evaluation (Paterson), University of Toronto, Toronto, Ont.; Manitoba Centre for Health Policy, Department of Community Health Sciences (Dahl, Kuo), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; Department of Anesthesiology, Pharmacology and Therapeutics (Fisher), University of British Columbia, Vancouver BC; School of Pharmacy (Gamble), University of Waterloo, Kitchener, Ont.; Department of Community Health Sciences (Ronksley), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Saskatchewan Health Quality Council (Winquist); Department of Community Health and Epidemiology (Winquist), College of Medicine, University of Saskatchewan, Saskatoon Sask.; Departments of Medicine and of Epidemiology, Biostatistics, and Occupational Health (Filion), McGill University, Montréal, Que.
Reynier P; Centre for Clinical Epidemiology (Moriello, Reynier, Aibibula, Filion), Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Que; ICES (Paterson); Institute of Health Policy, Management and Evaluation (Paterson), University of Toronto, Toronto, Ont.; Manitoba Centre for Health Policy, Department of Community Health Sciences (Dahl, Kuo), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; Department of Anesthesiology, Pharmacology and Therapeutics (Fisher), University of British Columbia, Vancouver BC; School of Pharmacy (Gamble), University of Waterloo, Kitchener, Ont.; Department of Community Health Sciences (Ronksley), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Saskatchewan Health Quality Council (Winquist); Department of Community Health and Epidemiology (Winquist), College of Medicine, University of Saskatchewan, Saskatoon Sask.; Departments of Medicine and of Epidemiology, Biostatistics, and Occupational Health (Filion), McGill University, Montréal, Que.
Dahl M; Centre for Clinical Epidemiology (Moriello, Reynier, Aibibula, Filion), Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Que; ICES (Paterson); Institute of Health Policy, Management and Evaluation (Paterson), University of Toronto, Toronto, Ont.; Manitoba Centre for Health Policy, Department of Community Health Sciences (Dahl, Kuo), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; Department of Anesthesiology, Pharmacology and Therapeutics (Fisher), University of British Columbia, Vancouver BC; School of Pharmacy (Gamble), University of Waterloo, Kitchener, Ont.; Department of Community Health Sciences (Ronksley), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Saskatchewan Health Quality Council (Winquist); Department of Community Health and Epidemiology (Winquist), College of Medicine, University of Saskatchewan, Saskatoon Sask.; Departments of Medicine and of Epidemiology, Biostatistics, and Occupational Health (Filion), McGill University, Montréal, Que.
Aibibula W; Centre for Clinical Epidemiology (Moriello, Reynier, Aibibula, Filion), Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Que; ICES (Paterson); Institute of Health Policy, Management and Evaluation (Paterson), University of Toronto, Toronto, Ont.; Manitoba Centre for Health Policy, Department of Community Health Sciences (Dahl, Kuo), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; Department of Anesthesiology, Pharmacology and Therapeutics (Fisher), University of British Columbia, Vancouver BC; School of Pharmacy (Gamble), University of Waterloo, Kitchener, Ont.; Department of Community Health Sciences (Ronksley), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Saskatchewan Health Quality Council (Winquist); Department of Community Health and Epidemiology (Winquist), College of Medicine, University of Saskatchewan, Saskatoon Sask.; Departments of Medicine and of Epidemiology, Biostatistics, and Occupational Health (Filion), McGill University, Montréal, Que.
Fisher A; Centre for Clinical Epidemiology (Moriello, Reynier, Aibibula, Filion), Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Que; ICES (Paterson); Institute of Health Policy, Management and Evaluation (Paterson), University of Toronto, Toronto, Ont.; Manitoba Centre for Health Policy, Department of Community Health Sciences (Dahl, Kuo), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; Department of Anesthesiology, Pharmacology and Therapeutics (Fisher), University of British Columbia, Vancouver BC; School of Pharmacy (Gamble), University of Waterloo, Kitchener, Ont.; Department of Community Health Sciences (Ronksley), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Saskatchewan Health Quality Council (Winquist); Department of Community Health and Epidemiology (Winquist), College of Medicine, University of Saskatchewan, Saskatoon Sask.; Departments of Medicine and of Epidemiology, Biostatistics, and Occupational Health (Filion), McGill University, Montréal, Que.
Gamble JM; Centre for Clinical Epidemiology (Moriello, Reynier, Aibibula, Filion), Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Que; ICES (Paterson); Institute of Health Policy, Management and Evaluation (Paterson), University of Toronto, Toronto, Ont.; Manitoba Centre for Health Policy, Department of Community Health Sciences (Dahl, Kuo), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; Department of Anesthesiology, Pharmacology and Therapeutics (Fisher), University of British Columbia, Vancouver BC; School of Pharmacy (Gamble), University of Waterloo, Kitchener, Ont.; Department of Community Health Sciences (Ronksley), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Saskatchewan Health Quality Council (Winquist); Department of Community Health and Epidemiology (Winquist), College of Medicine, University of Saskatchewan, Saskatoon Sask.; Departments of Medicine and of Epidemiology, Biostatistics, and Occupational Health (Filion), McGill University, Montréal, Que.
Kuo IF; Centre for Clinical Epidemiology (Moriello, Reynier, Aibibula, Filion), Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Que; ICES (Paterson); Institute of Health Policy, Management and Evaluation (Paterson), University of Toronto, Toronto, Ont.; Manitoba Centre for Health Policy, Department of Community Health Sciences (Dahl, Kuo), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; Department of Anesthesiology, Pharmacology and Therapeutics (Fisher), University of British Columbia, Vancouver BC; School of Pharmacy (Gamble), University of Waterloo, Kitchener, Ont.; Department of Community Health Sciences (Ronksley), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Saskatchewan Health Quality Council (Winquist); Department of Community Health and Epidemiology (Winquist), College of Medicine, University of Saskatchewan, Saskatoon Sask.; Departments of Medicine and of Epidemiology, Biostatistics, and Occupational Health (Filion), McGill University, Montréal, Que.
Ronksley PE; Centre for Clinical Epidemiology (Moriello, Reynier, Aibibula, Filion), Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Que; ICES (Paterson); Institute of Health Policy, Management and Evaluation (Paterson), University of Toronto, Toronto, Ont.; Manitoba Centre for Health Policy, Department of Community Health Sciences (Dahl, Kuo), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; Department of Anesthesiology, Pharmacology and Therapeutics (Fisher), University of British Columbia, Vancouver BC; School of Pharmacy (Gamble), University of Waterloo, Kitchener, Ont.; Department of Community Health Sciences (Ronksley), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Saskatchewan Health Quality Council (Winquist); Department of Community Health and Epidemiology (Winquist), College of Medicine, University of Saskatchewan, Saskatoon Sask.; Departments of Medicine and of Epidemiology, Biostatistics, and Occupational Health (Filion), McGill University, Montréal, Que.
Winquist B; Centre for Clinical Epidemiology (Moriello, Reynier, Aibibula, Filion), Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Que; ICES (Paterson); Institute of Health Policy, Management and Evaluation (Paterson), University of Toronto, Toronto, Ont.; Manitoba Centre for Health Policy, Department of Community Health Sciences (Dahl, Kuo), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; Department of Anesthesiology, Pharmacology and Therapeutics (Fisher), University of British Columbia, Vancouver BC; School of Pharmacy (Gamble), University of Waterloo, Kitchener, Ont.; Department of Community Health Sciences (Ronksley), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Saskatchewan Health Quality Council (Winquist); Department of Community Health and Epidemiology (Winquist), College of Medicine, University of Saskatchewan, Saskatoon Sask.; Departments of Medicine and of Epidemiology, Biostatistics, and Occupational Health (Filion), McGill University, Montréal, Que.
Filion KB; Centre for Clinical Epidemiology (Moriello, Reynier, Aibibula, Filion), Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Que; ICES (Paterson); Institute of Health Policy, Management and Evaluation (Paterson), University of Toronto, Toronto, Ont.; Manitoba Centre for Health Policy, Department of Community Health Sciences (Dahl, Kuo), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; Department of Anesthesiology, Pharmacology and Therapeutics (Fisher), University of British Columbia, Vancouver BC; School of Pharmacy (Gamble), University of Waterloo, Kitchener, Ont.; Department of Community Health Sciences (Ronksley), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Saskatchewan Health Quality Council (Winquist); Department of Community Health and Epidemiology (Winquist), College of Medicine, University of Saskatchewan, Saskatoon Sask.; Departments of Medicine and of Epidemiology, Biostatistics, and Occupational Health (Filion), McGill University, Montréal, Que. .
Pokaż więcej
Corporate Authors :
Canadian Network for Observational Drug Effect Studies (CNODES) Investigators
Źródło :
CMAJ open [CMAJ Open] 2021 May 14; Vol. 9 (2), pp. E500-E509. Date of Electronic Publication: 2021 May 14 (Print Publication: 2021).
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Death, Sudden, Cardiac*/epidemiology
Death, Sudden, Cardiac*/etiology
Death, Sudden, Cardiac*/prevention & control
Drug Utilization*/statistics & numerical data
Drug Utilization*/trends
Postpartum Period*
Tachycardia, Ventricular*/chemically induced
Tachycardia, Ventricular*/diagnosis
Tachycardia, Ventricular*/epidemiology
Domperidone/*adverse effects
Lactation Disorders/*drug therapy
Off-Label Use/*statistics & numerical data
Adult ; Antiemetics/adverse effects ; Canada/epidemiology ; Female ; Humans ; Interrupted Time Series Analysis ; Lactation/drug effects ; Practice Patterns, Physicians'/statistics & numerical data ; Pregnancy ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł :
A real-world data approach to determine the optimal dosing strategy for pembrolizumab.
Autorzy :
Jang A; Provincial Pharmacy, BC Cancer, Vancouver, Canada.; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.
Nakashima L; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Ng T; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Fung M; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Jiwani S; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Schaff K; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Suess J; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Goncalves R; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Jang D; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Kuik K; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Labelle S; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Pow A; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Pokaż więcej
Źródło :
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2021 Apr; Vol. 27 (3), pp. 635-643. Date of Electronic Publication: 2020 Jun 15.
Typ publikacji :
Journal Article; Multicenter Study; Pragmatic Clinical Trial
MeSH Terms :
Antibodies, Monoclonal, Humanized/*administration & dosage
Antineoplastic Agents, Immunological/*administration & dosage
Cost Savings/*statistics & numerical data
Drug Costs/*statistics & numerical data
Drug Utilization Review/*statistics & numerical data
Antibodies, Monoclonal, Humanized/economics ; Antineoplastic Agents, Immunological/economics ; British Columbia/epidemiology ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/economics ; Carcinoma, Non-Small-Cell Lung/epidemiology ; Cost Savings/methods ; Cost-Benefit Analysis/methods ; Cost-Benefit Analysis/statistics & numerical data ; Dose-Response Relationship, Drug ; Drug Utilization Review/economics ; Drug Utilization Review/methods ; Female ; Humans ; Lung Neoplasms/drug therapy ; Lung Neoplasms/economics ; Lung Neoplasms/epidemiology ; Male ; Melanoma/drug therapy ; Melanoma/economics ; Melanoma/epidemiology ; Retrospective Studies ; Skin Neoplasms/drug therapy ; Skin Neoplasms/economics ; Skin Neoplasms/epidemiology
Czasopismo naukowe
Tytuł :
Prevalence and risk factors for antibiotic utilization in Chinese children.
Autorzy :
Guo S; Centre for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.; NHC Key Lab of Health Economics and Policy Research (Shandong University), Jinan, 250012, China.
Sun Q; Centre for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.; NHC Key Lab of Health Economics and Policy Research (Shandong University), Jinan, 250012, China.
Zhao X; School of Nursing, China Medical University, Shenyang, 110100, China.
Shen L; Centre for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.; NHC Key Lab of Health Economics and Policy Research (Shandong University), Jinan, 250012, China.
Zhen X; Centre for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China. .; NHC Key Lab of Health Economics and Policy Research (Shandong University), Jinan, 250012, China. .
Pokaż więcej
Źródło :
BMC pediatrics [BMC Pediatr] 2021 Jun 01; Vol. 21 (1), pp. 255. Date of Electronic Publication: 2021 Jun 01.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Anti-Bacterial Agents*/therapeutic use
Drug Utilization*
Child ; China/epidemiology ; Drug Resistance, Microbial ; Humans ; Prevalence ; Risk Factors
Czasopismo naukowe
Tytuł :
Medication Use Patterns in Hospitalized Patients With COVID-19 in California During the Pandemic.
Autorzy :
Watanabe JH; Department of Clinical Pharmacy Practice, University of California Irvine School of Pharmacy & Pharmaceutical Sciences, Irvine.
Kwon J; Department of Statistics, University of California, Irvine Donald Bren School of Information and Computer Sciences, Irvine.
Nan B; Department of Statistics, University of California, Irvine Donald Bren School of Information and Computer Sciences, Irvine.
Abeles SR; Antimicrobial Stewardship, Infection Prevention and Clinical Epidemiology, Department of Medicine, University of California, San Diego School of Medicine, La Jolla.
Jia S; Department of Clinical Pharmacy Practice, University of California Irvine School of Pharmacy & Pharmaceutical Sciences, Irvine.
Mehta SR; Infectious Disease Section, VA San Diego Clinical Microbiology Laboratory, VA San Diego, La Jolla, California.; Department of Medicine, UC San Diego School of Medicine, La Jolla, California.
Pokaż więcej
Źródło :
JAMA network open [JAMA Netw Open] 2021 May 03; Vol. 4 (5), pp. e2110775. Date of Electronic Publication: 2021 May 03.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Utilization Review*
COVID-19/*drug therapy
Adenosine Monophosphate/analogs & derivatives ; Adenosine Monophosphate/therapeutic use ; Adult ; Alanine/analogs & derivatives ; Alanine/therapeutic use ; Angiotensin Receptor Antagonists/therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Anti-Bacterial Agents/therapeutic use ; Anti-Inflammatory Agents/therapeutic use ; Anticoagulants/therapeutic use ; Antiviral Agents/therapeutic use ; Azithromycin/therapeutic use ; COVID-19/epidemiology ; California/epidemiology ; Colchicine/therapeutic use ; Dexamethasone/therapeutic use ; Drug Therapy, Combination ; Female ; Hospitalization ; Humans ; Hydrocortisone/therapeutic use ; Hydroxychloroquine/therapeutic use ; Male ; Pandemics ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Drug-utilisation profiles and COVID-19.
Autorzy :
Orlando V; CIRFF, Center of Drug Utilisation and Pharmacoeconomics, University of Naples Federico II, 80131, Naples, Italy. .; Department of Pharmacy, Center of Drug Utilisation and Pharmacoeconomics, University of Naples Federico II, 80131, Naples, Italy. .
Coscioni E; Division of Cardiac Surgery, AOU San Giovanni di Dio E Ruggi d'Aragona, 84131, Salerno, Italy.
Guarino I; CIRFF, Center of Drug Utilisation and Pharmacoeconomics, University of Naples Federico II, 80131, Naples, Italy.
Mucherino S; CIRFF, Center of Drug Utilisation and Pharmacoeconomics, University of Naples Federico II, 80131, Naples, Italy.; Department of Pharmacy, Center of Drug Utilisation and Pharmacoeconomics, University of Naples Federico II, 80131, Naples, Italy.
Perrella A; Infectious Disease of Healthcare Direction, AORN Antonio Cardarelli, 80131, Naples, Italy.
Trama U; Regional Pharmaceutical Unit, Campania Region, 80143, Naples, Italy.
Limongelli G; Department of Translational Medical Science, University of Campania Luigi Vanvitelli, Monaldi Hospital, 80131, Naples, Italy.
Menditto E; CIRFF, Center of Drug Utilisation and Pharmacoeconomics, University of Naples Federico II, 80131, Naples, Italy. .; Department of Pharmacy, Center of Drug Utilisation and Pharmacoeconomics, University of Naples Federico II, 80131, Naples, Italy. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2021 Apr 26; Vol. 11 (1), pp. 8913. Date of Electronic Publication: 2021 Apr 26.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Utilization Review*
COVID-19/*drug therapy
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; COVID-19/epidemiology ; COVID-19/virology ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Infant, Newborn ; Italy/epidemiology ; Male ; Middle Aged ; Renin-Angiotensin System/drug effects ; SARS-CoV-2/isolation & purification ; Young Adult
Czasopismo naukowe
Tytuł :
Use of antipsychotics in Denmark 1997-2018: a nation-wide drug utilisation study with focus on off-label use and associated diagnoses.
Autorzy :
Højlund M; Department of Public Health, Clinical Pharmacology, Pharmacy, and Environmental Medicine, University of Southern Denmark, Odense, Denmark.; Mental Health Services Region of Southern Denmark, Department of Psychiatry Aabenraa, Aabenraa, Denmark.
Andersen JH; Department of Public Health, Clinical Pharmacology, Pharmacy, and Environmental Medicine, University of Southern Denmark, Odense, Denmark.
Andersen K; Department of Clinical Research, Psychiatry, University of Southern Denmark, Odense, Denmark.; Mental Health Services Region of Southern Denmark, Department of Psychiatry Odense, Odense, Denmark.
Correll CU; Department of Psychiatry, The Zucker Hillside Hospital, Zucker School of Medicine at Hofstra/Northwell, New York, USA.; Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.; Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany.
Hallas J; Department of Public Health, Clinical Pharmacology, Pharmacy, and Environmental Medicine, University of Southern Denmark, Odense, Denmark.
Pokaż więcej
Źródło :
Epidemiology and psychiatric sciences [Epidemiol Psychiatr Sci] 2021 Apr 06; Vol. 30, pp. e28. Date of Electronic Publication: 2021 Apr 06.
Typ publikacji :
Journal Article
MeSH Terms :
Antipsychotic Agents*/therapeutic use
Drug Utilization*/statistics & numerical data
Mental Disorders*/diagnosis
Mental Disorders*/drug therapy
Mental Disorders*/epidemiology
Off-Label Use*/statistics & numerical data
Denmark/epidemiology ; Humans
Czasopismo naukowe
Tytuł :
Use of antiseizure medications and safety of branded versus generic formulations: A comparative study on Tuscan administrative databases.
Autorzy :
Giometto S; Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy. Electronic address: .
Baglietto L; Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy. Electronic address: .
Conte M; Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
Vannacci A; Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy. Electronic address: .
Tuccori M; Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy.
Mugelli A; Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy. Electronic address: .
Gini R; Agenzia regionale di sanità della Toscana, Florence, Italy. Electronic address: .
Lucenteforte E; Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy. Electronic address: .
Pokaż więcej
Źródło :
Epilepsy & behavior : E&B [Epilepsy Behav] 2021 Apr; Vol. 117, pp. 107876. Date of Electronic Publication: 2021 Mar 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Utilization*
Drugs, Generic*/therapeutic use
Databases, Factual ; Humans ; Italy ; Seizures
Czasopismo naukowe
Tytuł :
Antibiotic use in the COVID-19 crisis in Spain.
Autorzy :
Gonzalez-Zorn B; Antimicrobial Resistance Unit, Veterinary School and VISAVET, Complutense University of Madrid, Spain. Electronic address: .
Pokaż więcej
Źródło :
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2021 Apr; Vol. 27 (4), pp. 646-647. Date of Electronic Publication: 2020 Nov 25.
Typ publikacji :
Letter
MeSH Terms :
Anti-Bacterial Agents/*therapeutic use
Bacterial Infections/*drug therapy
COVID-19/*epidemiology
Drug Utilization/*statistics & numerical data
COVID-19/complications ; COVID-19/microbiology ; Drug Resistance, Multiple, Bacterial ; Drug Utilization/standards ; Hospitals/statistics & numerical data ; Humans ; Spain/epidemiology
Opinia redakcyjna
Tytuł :
Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis.
Autorzy :
Langford BJ; Public Health Ontario, ON, Canada; Hotel Dieu Shaver Health and Rehabilitation Centre, ON, Canada. Electronic address: .
So M; Sinai Health-University Health Network Antimicrobial Stewardship Program, University Health Network, Toronto, Canada; University of Toronto, ON, Canada; Toronto General Hospital Research Institute, Toronto, ON, Canada.
Raybardhan S; North York General Hospital, ON, Canada.
Leung V; Public Health Ontario, ON, Canada; Toronto East Health Network, Michael Garron Hospital, ON, Canada.
Soucy JR; Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, ON, Canada.
Westwood D; Sunnybrook Research Institute, ON, Canada.
Daneman N; Public Health Ontario, ON, Canada; University of Toronto, ON, Canada; Sunnybrook Research Institute, ON, Canada; ICES (formerly Institute for Clinical Evaluative Sciences), ON, Canada.
MacFadden DR; Ottawa Hospital Research Institute, ON, Canada.
Pokaż więcej
Źródło :
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2021 Apr; Vol. 27 (4), pp. 520-531. Date of Electronic Publication: 2021 Jan 05.
Typ publikacji :
Journal Article; Meta-Analysis; Review
MeSH Terms :
COVID-19*/complications
Drug Prescriptions*
Drug Utilization*
Anti-Bacterial Agents/*therapeutic use
Age Factors ; Antimicrobial Stewardship ; Bacterial Infections/complications ; Bacterial Infections/drug therapy ; Bacterial Infections/epidemiology ; Coinfection/drug therapy ; Coinfection/epidemiology ; Female ; Humans ; Male
Czasopismo naukowe
Tytuł :
Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000-15: an analysis of pharmaceutical sales data.
Autorzy :
Klein EY; Center for Disease Dynamics, Economics & Policy, Washington, DC, USA; Department of Emergency Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address: .
Milkowska-Shibata M; Center for Disease Dynamics, Economics & Policy, Washington, DC, USA.
Tseng KK; Center for Disease Dynamics, Economics & Policy, Washington, DC, USA.
Sharland M; Paediatric Infectious Diseases Research Group, Institute for Infection and Immunity, St George's University of London, London, UK.
Gandra S; Division of Infectious Diseases, Department of Internal Medicine, Washington University School of Medicine, St Louis, MO, USA.
Pulcini C; APEMAC, University of Lorraine, Nancy, France; Infectious Diseases Department, University of Lorraine, Nancy, France.
Laxminarayan R; Center for Disease Dynamics, Economics & Policy, Washington, DC, USA; Princeton Environmental Institute, Princeton University, Princeton, NJ, USA; Department of Global Health, University of Washington, Seattle, WA, USA.
Pokaż więcej
Źródło :
The Lancet. Infectious diseases [Lancet Infect Dis] 2021 Jan; Vol. 21 (1), pp. 107-115. Date of Electronic Publication: 2020 Jul 24.
Typ publikacji :
Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Anti-Bacterial Agents/*economics
Commerce/*economics
Commerce/*trends
Developing Countries/*statistics & numerical data
Drug Utilization/*economics
Drug Utilization/*trends
Pharmaceutical Preparations/*economics
Antimicrobial Stewardship ; Commerce/statistics & numerical data ; Drug Utilization/statistics & numerical data ; Forecasting ; Humans ; World Health Organization
Czasopismo naukowe
Tytuł :
Comparing outpatient oral antibiotic use in Germany and the Netherlands from 2012 to 2016.
Autorzy :
Gradl G; German Institute for Drug Use Evaluation (DAPI), Berlin, DE, Germany.
Teichert M; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
Kieble M; German Institute for Drug Use Evaluation (DAPI), Berlin, DE, Germany.
Werning J; German Institute for Drug Use Evaluation (DAPI), Berlin, DE, Germany.
Schulz M; German Institute for Drug Use Evaluation (DAPI), Berlin, DE, Germany.; Department of Medicine, ABDA-Federal Union of German Associations of Pharmacists, Berlin, DE, Germany.; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universitaet Berlin, Berlin, DE, Germany.
Pokaż więcej
Źródło :
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2018 Dec; Vol. 27 (12), pp. 1344-1355. Date of Electronic Publication: 2018 Sep 28.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Drug Utilization Review*
Ambulatory Care/*statistics & numerical data
Anti-Bacterial Agents/*administration & dosage
Drug Utilization/*statistics & numerical data
Administration, Oral ; Adolescent ; Age Factors ; Ambulatory Care/trends ; Child ; Child, Preschool ; Databases, Factual/statistics & numerical data ; Drug Prescriptions/standards ; Drug Prescriptions/statistics & numerical data ; Drug Utilization/standards ; Drug Utilization/trends ; Germany ; Humans ; Infant ; Infant, Newborn ; Longitudinal Studies ; Netherlands ; Pharmacies/statistics & numerical data ; Practice Guidelines as Topic
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies